Description: Nanollose Limited is an Australia-based biotechnology company. The Company is focused on discovering, developing and commercializing novel products and processes related to microbial nanocellulose. It has developed a proprietary technology for production, processing and applications of microbial nanocellulose called the Plant-free cellulose technology. Its technology modifies the structure of nanocellulose by physical or chemical treatments to produce novel modified fibers or other materials. It seeks to commercialize the production and use of Plant-Free cellulose as an alternative to cotton, tree pulp and other materials used in the textile industry. It has also identified applications in the horticulture industry, specifically for seed germination. It also serves other industries, including medical applications, personal hygiene markets, materials such as paper, packaging and cardboard, biodegradable plastic and films, and food applications, such as food supplements.
Home Page: www.nanollose.com
NC6 Technical Analysis
CPC
Nedlands,
WA
6009
Australia
Phone:
61 8 9389 3120
Officers
| Name | Title |
|---|---|
| Dr. Wayne Morris Best BSc (Hons), DIC, FRACI, GAICD, Ph.D. | Exec. Chairman |
| Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.6856 |
| Price-to-Sales TTM: | 39.7717 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |